Figure 2
From: Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer
The reliability of MEG3 promoter methylation in plasma. (a) The level of MEG3 methylation in plasma presented a notable positive correlation with that in tissues of same patient. (b,c) A significantly higher methylation level was observed in DNA samples from preoperative plasmas as compared to postoperative plasmas. **P < 0.01.
